Biogen Inc/ US09062X1037 /
| 07.11.2024 18:56:31 | Diff. +0,5200 | Volumen | Geld18:57:00 | Brief18:57:00 | Marktkapitalisierung | Dividendenr. | KGV |
|---|---|---|---|---|---|---|---|
| 174,9200USD | +0,30% | 359.609 Umsatz: 40,14 Mio. |
174,9100Geld Vol: 300 | 175,0000Brief Vol: 800 | 25,46 Mrd.USD | - | 21,79 |
Aktiva
|
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
2023 US GAAP in Mio. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sachanlagen | 3.247,3000 | 3.411,5000 | 3.416,4000 | 3.298,6000 | 3.309,7000 | ||||||
| Immaterielle Vermögensgegenstände | 3.527,4000 | 3.084,3000 | 2.221,3000 | 1.850,1000 | 8.363 | ||||||
| Finanzanlagen | 1.408,1000 | 772,1000 | 892 | 705,7000 | 0.0000 | ||||||
| Anlagevermögen | 18.852,5000 | 17.731,8000 | 16.020,8000 | 14.762,9000 | 19.985,5000 | ||||||
| Vorräte | 804,2000 | 1.068,6000 | 1.351,5000 | 1.344,4000 | 2.527,4000 | ||||||
| Forderungen | 1.880,5000 | 1.913,8000 | 1.549,4000 | 1.705 | 1.664,1000 | ||||||
| Liquide Mitteln | 2.913,7000 | 1.331,2000 | 2.261,4000 | 3.419,3000 | 1.049,9000 | ||||||
| Umlaufvermögen | 8.381,8000 | 6.887,1000 | 7.856,5000 | 9.791,2000 | 6.859,3000 | ||||||
| Aktiva, gesamt | 27.234,3000 | 24.618,9000 | 23.877,3000 | 24.554,1000 | 26.844,8000 | ||||||
Passiva
|
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
2023 US GAAP in Mio. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Verbindlichkeiten aus Lieferungen und Leistungen | 530,8000 | 454,9000 | 589,2000 | 491,5000 | 403,3000 | ||||||
| Langfristige Schulden | 4.459 | 7.426,2000 | 6.274 | 6.281 | 6.788,2000 | ||||||
| Verbindlichkeiten gegenüber Kreditinstituten | 4.459 | 7.426,2000 | 6.274 | - | - | ||||||
| Rückstellungen | 2.882,2000 | 1.174,8000 | 869,2000 | - | - | ||||||
| Verbindlichkeiten | 13.895,2000 | 13.932,8000 | 12.917,6000 | 11.165,7000 | 12.045,4000 | ||||||
| Gezeichnetes Kapital | ,1000 | ,1000 | ,1000 | ,1000 | ,1000 | ||||||
| Eigenkapital | 13.339,1000 | 10.686,1000 | 10.959,7000 | 13.388,4000 | 14.799,4000 | ||||||
| Minderheitenanteile | -4,1000 | -14,2000 | 63,5000 | -9,5000 | 0.0000 | ||||||
| Passiva, gesamt | 27.234,3000 | 24.618,9000 | 23.877,3000 | 24.554,1000 | 26.844,8000 | ||||||
Gewinn- und Verlustrechnung
|
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
2023 US GAAP in Mio. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 14.377,9000 | 13.444,6000 | 10.981,7000 | 10.173,4000 | 9.835,6000 | ||||||
| Abschreibungen (Gesamt) | 680,6000 | 457,2000 | 487,7000 | 518,4000 | 494,8000 | ||||||
| Betriebsergebnis | 7.042,6000 | 4.550,1000 | 2.840,7000 | - | - | ||||||
| Zinsergebnis | -67,4000 | -180,5000 | -242,6000 | -157,3000 | -29,6000 | ||||||
| Ergebnis vor Steuern | 7.125,9000 | 5.047,5000 | 1.745,2000 | 3.591,8000 | 1.296,8000 | ||||||
| Ertragsteuern | 1.158 | 992,3000 | 52,5000 | 632,8000 | 135,3000 | ||||||
| Gewinnanteil Minderheitsgesellschafter | 0.0000 | 59,9000 | 171,5000 | -85,3000 | ,4000 | ||||||
| Konzernjahresüberschuss | 5.888,5000 | 4.000,6000 | 1.556,1000 | 3.046,9000 | 1.161,1000 | ||||||
Pro Aktie
Cash Flow
|
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
2023 US GAAP in Mio. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow aus laufender Geschäftstätigkeit | 7.078,6000 | 4.229,8000 | 3.639,9000 | 1.384,3000 | 1.547,2000 | ||||||
| Cash Flow aus Investitionstätigkeit | 470,5000 | -608,6000 | -563,7000 | 1.576,6000 | -4.101 | ||||||
| Cash Flow aus Finanzierungstätigkeit | -5.860,4000 | -5.272,7000 | -2.086,2000 | -1.747,3000 | 149,3000 | ||||||
| Veränderung der liquiden Mittel | 1.688,7000 | -1.651,5000 | 990 | 1.213,6000 | -2.404,5000 | ||||||
| Anzahl der Mitarbeiter | 7.400 | 9.100 | 9.610 | - | - | ||||||
